dobutamine has been researched along with ivabradine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Böhm, M; Link, A; Reil, JC; Selejan, S | 1 |
| Bonagura, JD; Li, X; Otoni, CC; Riesen, SC; Schober, KE; Smith, DN | 1 |
| Busseuil, D; Davy, JM; Lattuca, B; Leclercq, F; Rhéaume, E; Roubille, F; Tardif, JC | 1 |
| Cavusoglu, Y; Mert, U; Morrad, B; Mutlu, F; Nadir, A; Ulus, T | 1 |
| Bremont, C; Damy, T; Dubois-Rande, JL; Gallet, R; Guendouz, S; Gueret, P; Lim, P; Seemann, A; Ternacle, J | 1 |
| Bakkehaug, JP; How, OJ; Kildal, AB; Myrmel, T; Naesheim, T; Torgersen Engstad, E | 1 |
| Akodad, M; Lim, P; Roubille, F | 1 |
| Çavuşoglu, Y; Mert, GÖ; Mert, KU; Morrad, B; Mutlu, F; Tahmazov, S | 1 |
| Amour, J; Apert-Verneuil, C; Bouabdallah, K; Carbognani, D; Cholley, B; Moyne, A; Nguyen, LS; Squara, P; Thierry, S | 1 |
| Bakkehaug, JP; How, OJ; Kildal, AB; Myrmel, T; Rødland, L; Rønning, L | 1 |
| Carafa, MRP; Flammia, FC; Larici, AR; Lo Piccolo, F; Marano, R; Meduri, A; Merlino, B; Natale, L; Rovere, G; Savino, G | 1 |
1 review(s) available for dobutamine and ivabradine
| Article | Year |
|---|---|
Practical instructions for using drugs in CT and MR cardiac imaging.
Topics: Adenosine; Adrenergic beta-Antagonists; Anti-Anxiety Agents; Atropine; Calcium Channel Blockers; Cardiac Imaging Techniques; Computed Tomography Angiography; Contraindications, Drug; Coronary Angiography; Coronary Vessels; Dipyridamole; Dobutamine; Heart; Humans; Ivabradine; Magnetic Resonance Imaging; Nitroglycerin; Purines; Pyrazoles; Vasodilator Agents | 2021 |
2 trial(s) available for dobutamine and ivabradine
| Article | Year |
|---|---|
Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged | 2015 |
Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial.
Topics: Administration, Intravenous; Aged; Cardiac Output, Low; Cardiotonic Agents; Cardiovascular Agents; Coronary Artery Bypass; Dobutamine; Elective Surgical Procedures; Female; Humans; Ivabradine; Male; Middle Aged; Placebos; Single-Blind Method | 2018 |
8 other study(ies) available for dobutamine and ivabradine
| Article | Year |
|---|---|
Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure.
Topics: Acute Disease; Benzazepines; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Tachycardia, Sinus; Treatment Outcome | 2009 |
Effects of ivabradine on heart rate and left ventricular function in healthy cats and cats with hypertrophic cardiomyopathy.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Benzazepines; Blood Pressure; Cardiomyopathy, Hypertrophic; Cardiovascular Agents; Cat Diseases; Cats; Dobutamine; Dose-Response Relationship, Drug; Heart Rate; Ivabradine; Propanolamines; Ventricular Function, Left | 2012 |
Is ivabradine suitable to control undesirable tachycardia induced by dobutamine in cardiogenic shock treatment?
Topics: Benzazepines; Dobutamine; Humans; Ivabradine; Models, Theoretical; Tachycardia | 2013 |
Hemodynamic effects of Ivabradine in addition to dobutamine in patients with severe systolic dysfunction.
Topics: Aged; Benzazepines; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Female; Heart Failure, Systolic; Hemodynamics; Humans; Ivabradine; Male; Middle Aged; Pilot Projects; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2014 |
Reversing dobutamine-induced tachycardia using ivabradine increases stroke volume with neutral effect on cardiac energetics in left ventricular post-ischaemia dysfunction.
Topics: Animals; Benzazepines; Cardiac Output; Cardiotonic Agents; Coronary Circulation; Dobutamine; Energy Metabolism; Heart; Heart Rate; In Vitro Techniques; Ivabradine; Male; Mice; Myocardial Ischemia; Myocardium; Oxygen Consumption; Stroke Volume; Swine; Tachycardia; Ventricular Dysfunction, Left | 2016 |
Does ivabradine balance dobutamine effects in cardiogenic shock? A promising new strategy.
Topics: Benzazepines; Dobutamine; Humans; Ivabradine; Shock, Cardiogenic | 2016 |
Effects of ivabradine and beta-blocker therapy on dobutamine-induced ventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Dobutamine; Electrocardiography, Ambulatory; Female; Humans; Ivabradine; Male; Middle Aged | 2017 |
Opposite diastolic effects of omecamtiv mecarbil versus dobutamine and ivabradine co-treatment in pigs with acute ischemic heart failure.
Topics: Animals; Cardiotonic Agents; Cardiovascular Agents; Diastole; Dobutamine; Drug Therapy, Combination; Heart Failure; Ivabradine; Male; Myocardial Ischemia; Swine; Treatment Outcome; Urea | 2018 |